Seeing Is Believing
Currently out of the existing stock ratings of Rahul Sarugaser, 19 are a BUY (79.17%), 5 are a HOLD (20.83%).
Analyst Rahul Sarugaser, currently employed at RAYMOND JAMES, carries an average stock price target met ratio of 52.08% that have a potential upside of 74.4% achieved within 109 days.
Rahul Sarugaser’s has documented 44 price targets and ratings displayed on 11 stocks. The coverage is on Consumer Defensive, Technology, Healthcare sectors.
Most recent stock forecast was given on FUSN, Fusion Pharmaceuticals at 05-Jan-2024.
Analyst best performing recommendations are on DNA (GINKGO BIOWORKS HOLDINGS).
The best stock recommendation documented was for DNA (GINKGO BIOWORKS HOLDINGS) at 10/13/2021. The price target of $580 was fulfilled within 6 days with a profit of $170 (41.46%) receiving and performance score of 69.11.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$3
$2.55 (566.67%)
$8
2 years 8 months 21 days ago
(01-Apr-2022)
0/2 (0%)
$1.87 (165.49%)
What Year was the first public recommendation made by Rahul Sarugaser?